O. A. O'Connor Et Al. , "First Multicenter, Randomized Phase 3 Study in Patients (Pts) with Relapsed/Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL): Alisertib (MLN8237) Versus Investigator's Choice (Lumiere trial; NCT01482962)," 57th Annual Meeting of the American-Society-of-Hematology , vol.126, Florida, United States Of America, 2015
O'Connor, O. A. Et Al. 2015. First Multicenter, Randomized Phase 3 Study in Patients (Pts) with Relapsed/Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL): Alisertib (MLN8237) Versus Investigator's Choice (Lumiere trial; NCT01482962). 57th Annual Meeting of the American-Society-of-Hematology , (Florida, United States Of America).
O'Connor, O. A., ÖZCAN, M., Jacobsen, E. D., Vidal, J. M. R., Trotman, J., Demeter, J., ... Masszi, T.(2015). First Multicenter, Randomized Phase 3 Study in Patients (Pts) with Relapsed/Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL): Alisertib (MLN8237) Versus Investigator's Choice (Lumiere trial; NCT01482962) . 57th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America
O'Connor, Owen Et Al. "First Multicenter, Randomized Phase 3 Study in Patients (Pts) with Relapsed/Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL): Alisertib (MLN8237) Versus Investigator's Choice (Lumiere trial; NCT01482962)," 57th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 2015
O'Connor, Owen A. Et Al. "First Multicenter, Randomized Phase 3 Study in Patients (Pts) with Relapsed/Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL): Alisertib (MLN8237) Versus Investigator's Choice (Lumiere trial; NCT01482962)." 57th Annual Meeting of the American-Society-of-Hematology , Florida, United States Of America, 2015
O'Connor, O. A. Et Al. (2015) . "First Multicenter, Randomized Phase 3 Study in Patients (Pts) with Relapsed/Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL): Alisertib (MLN8237) Versus Investigator's Choice (Lumiere trial; NCT01482962)." 57th Annual Meeting of the American-Society-of-Hematology , Florida, United States Of America.
@conferencepaper{conferencepaper, author={Owen A. O'Connor Et Al. }, title={First Multicenter, Randomized Phase 3 Study in Patients (Pts) with Relapsed/Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL): Alisertib (MLN8237) Versus Investigator's Choice (Lumiere trial; NCT01482962)}, congress name={57th Annual Meeting of the American-Society-of-Hematology}, city={Florida}, country={United States Of America}, year={2015}}